5 observations are made to Laurus Labs following a USFDA inspection of the Vizag plant

13 Dec 2023 , 12:49 PM

The pharmaceutical company Laurus Labs Ltd said on Tuesday, December 12, that the US Food and Drug Administration (FDA) has thoroughly inspected the wholly-owned subsidiary Laurus Synthesis Private Ltd (LSPL) at its manufacturing plant in Parawada, Anakapalli, close to Visakhapatnam, Andhra Pradesh.

Laurus Labs stated in a regulatory filing that the inspection, which took place between December 4 and 12, 2023, resulted in the issue of a Form 483 including five observations.

This is to notify you that the production plant located in Parawada, Anakapalli, close to Visakhapatnam, Andhra Pradesh, was inspected by the US FDA. Laurus Synthesis Private Limited (LSPL), a wholly owned subsidiary of Laurus Labs, undertook this examination. The examination took place between December 4 and December 12, 2023, according to the business.

Laurus Labs gave its stakeholders the reassurance that the business is dedicated to quickly addressing these observations.

For feedback and suggestions, write to us at [e-mail]